The immune-modulatory role of apolipoprotein e with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis

Clinical and Developmental Immunology

Volumn 2010, Issue , 2010, Pages

  Zhang, Hong Liang ^a   Wu, Jiang ^a,b   Zhu, Jie ^a,b  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BIOLOGICAL MARKER;

ADAPTIVE IMMUNITY; ALLELE; ALLERGIC ENCEPHALOMYELITIS; CLINICAL FEATURE; DISEASE CLASSIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; ANIMAL; AUTOIMMUNITY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY;

ANIMALS; APOLIPOPROTEINS E; AUTOIMMUNITY; BIOLOGICAL MARKERS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOMODULATION; MICE; MULTIPLE SCLEROSIS; OXIDATION-REDUCTION; POLYMORPHISM, GENETIC;

EID: 77953518270     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2010/186813     Document Type: Review

References (134)

1. Weisgraber K. H., Apolipoprotein E: structure-function relationships Advances in Protein Chemistry 1994 45 249 302
2. Raffa R. L., Dong L.-M., Farese R. V. Jr., Weisgraber K. H., Introduction of human apolipoprotein E4 domain interaction into mouse apolipoprotein E Proceedings of the National Academy of Sciences of the United States of America 2001 98 20 11587 11591
3. Li L., Thompson P. A., Kitchens R. L., Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors Journal of Lipid Research 2008 49 8 1782 1793
4. Mahley R. W., Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 1988 240 4852 622 630
5. Boyles J. K., Pitas R. E., Wilson E., Mahley R. W., Taylor J. M., Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system The Journal of Clinical Investigation 1985 76 4 1501 1513
6. Refolo L. M., Fillit H. M., Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer's disease Journal of Molecular Neuroscience 2004 23 3 151 155
7. Yancey P. G., Yu H., Linton M. F., Fazio S., A pathway-dependent on ApoE, ApoAI, and ABCA1 determines formation of buoyant high-density lipoprotein by macrophage foam cells Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 5 1123 1131
8. Knopman D. S., Roberts R. O., Geda Y. E., Association of prior stroke with cognitive function and cognitive impairment: a population-based study Archives of Neurology 2009 66 5 614 619
9. Kim J., Basak J. M., Holtzman D. M., The role of apolipoprotein E in Alzheimer's disease Neuron 2009 63 3 287 303
10. Guo Z., Fratiglioni L., Viitanen M., Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication? American Journal of Epidemiology 2001 153 3 225 231
11. Ewers M., Zhong Z., Brger K., Increased CSF-BACE 1 activity is associated with ApoE- 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease Brain 2008 131 5 1252 1258
12. Heun R., Ghne U., Luck T., Apolipoprotein E allele 4 is not a sufficient or a necessary predictor of the development of Mild Cognitive Impairment European Psychiatry 2010 25 1 15 18
13. Avila E. M., Holdsworth G., Sasaki N., Jackson R. L., Harmony J. A., Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells The Journal of Biological Chemistry 1982 257 10 5900 5909
14. Terkeltaub R. A., Dyer C. A., Martin J., Curtiss L. K., Apolipoprotein (Apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular Apo E and demonstration of Apo E binding to urate crystals in vivo The Journal of Clinical Investigation 1991 87 1 20 26
15. Vitek M. P., Brown C. M., Colton C. A., APOE genotype-specific differences in the innate immune response Neurobiology of Aging 2009 30 9 1350 1360
16. Barger S. W., Harmon A. D., Microglial activation by alzhelmer amyloid precursor protein and modulation by apolipoprotein E Nature 1997 388 6645 878 881
17. Colton C. A., Brown C. M., Czapiga M., Vitek M. P., Apolipoprotein-E allele-specific regulation of nitric oxide production Annals of the New York Academy of Sciences 2002 962 212 225
18. Colton C. A., Brown C. M., Cook D., APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress Neurobiology of Aging 2002 23 5 777 785
19. van den Elzen P., Garg S., Len L., Apolipoprotein-mediated pathways of lipid antigen presentation Nature 2005 437 7060 906 910
20. Borg N. A., Wun K. S., Kjer-Nielsen L., CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor Nature 2007 448 7149 44 49
21. Ophir G., Amariglio N., Jacob-Hirsch J., Elkon R., Rechavi G., Michaelson D. M., Apolipoprotein E4 enhances brain inflammation by modulation of the NF- B signaling cascade Neurobiology of Disease 2005 20 3 709 718
22. Schumacher K., Maerker-Alzer G., Wehmer U., A lymphocyte inhibiting factor isolated from normal human liver Nature 1974 251 5476 655 656
23. Fujii D. K., Edgington T. S., Direct suppression of lymphocyte induction by the immunoregulatory human serum low density lipoprotein, LDL-In The Journal of Immunology 1980 124 1 156 160
24. Hui D. Y., Harmony J. A. K., Phosphatidylinositol turnover in mitogen-activated lymphocytes. Suppression by low-density lipoproteins Biochemical Journal 1980 192 1 91 98
25. Hui D. Y., Harmony J. A. K., Innerarity T. L., Mahley R. W., Immunoregulatory plasma lipoproteins. Role of apoprotein E and apoprotein B The Journal of Biological Chemistry 1980 255 24 11775 11781
26. Pepe M. G., Curtiss L. K., Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In The Journal of Immunology 1986 136 10 3716 3723
27. Mistry M. J., Clay M. A., Kelly M. E., Steiner M. A., Harmony J. A. K., Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the G1A / G1B boundary Cellular Immunology 1995 160 1 14 23
28. Bocksch L., Stephens T., Lucas A., Singh B., Apolipoprotein E: possible therapeutic target for atherosclerosis Current Drug TargetsCardiovascular Haematological Disorders 2001 1 2 93 106
29. Getz G. S., Reardon C. A., Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall Journal of lipid research 2009 50 supplement S156 S161
30. Laurat E., Poirier B., Tupin E., In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice Circulation 2001 104 2 197 202
31. Ali K., Middleton M., Pur E., Rader D. J., Apolipoprotein E suppresses the type I inflammatory response in vivo Circulation Research 2005 97 9 922 927
32. Lynch J. R., Tang W., Wang H., APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response The Journal of Biological Chemistry 2003 278 49 48529 48533
33. Van Oosten M., Rensen P. C. N., Van Amersfoort E. S., Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality: a new therapeutic approach to treat gram-negative sepsis The Journal of Biological Chemistry 2001 276 12 8820 8824
34. de Bont N., Netea M. G., Demacker P. N. M., Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection Journal of Lipid Research 1999 40 4 680 685
35. Roselaar S. E., Daugherty A., Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo Journal of Lipid Research 1998 39 9 1740 1743
36. Martens G. W., Arikan M. C., Lee J., Ren F., Vallerskog T., Kornfeld H., Hypercholesterolemia impairs immunity to tuberculosis Infection and Immunity 2008 76 8 3464 3472
37. Gordon S., Alternative activation of macrophages Nature Reviews Immunology 2003 3 1 23 35
38. Lehnardt S., Massillon L., Follett P., Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8514 8519
39. Tenger C., Zhou X., Apolipoprotein E modulates immune activation by acting on the antigen-presenting cell Immunology 2003 109 3 392 397
40. Maezawa I., Nivison M., Montine K. S., Maeda N., Montine T. J., Neurotoxicity from innate immune response is greatest with targeted replacement of E4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK The FASEB Journal 2006 20 6 797 799
41. Saura J., Petegnief V., Wu X., Liang Y., Paul S. M., Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide Journal of Neurochemistry 2003 85 6 1455 1467
42. Werb Z., Chin J. R., Apoprotein E is synthesized and secreted by resident and thioglycollate-elicited macrophages but not by pyran copolymer- or bacillus Calmette-Guerin-activated macrophages The Journal of Experimental Medicine 1983 158 4 1272 1293
43. Vitek M. P., Snell J., Dawson H., Colton C. A., Modulation of nitric oxide production in human macrophages by apolipoprotein-E and amyloid-beta peptide Biochemical and Biophysical Research Communications 1997 240 2 391 394 (Pubitemid 27523670)
44. Czapiga M., Colton C. A., Microglial function in human APOE3 and APOE4 transgenic mice: altered arginine transport Journal of Neuroimmunology 2003 134 1-2 44 51
45. Laskowitz D. T., Lee D. M., Schmechel D., Staats H. F., Altered immune responses in apolipoprotein E-deficient mice Journal of Lipid Research 2000 41 4 613 620
46. Chaussabel D., Semnani R. T., McDowell M. A., Sacks D., Sher A., Nutman T. B., Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites Blood 2003 102 2 672 681
47. Le Naour F., Hohenkirk L., Grolleau A., Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics The Journal of Biological Chemistry 2001 276 21 17920 17931
48. Yoshimoto T., Bendelac A., Watson C., Hu-Li J., Paul W. E., Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production Science 1995 270 5243 1845 1847
49. Singh A. K., Wilson M. T., Hong S., Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis The Journal of Experimental Medicine 2001 194 12 1801 1811
50. Allan L. L., Hoefl K., Zheng D.-J., Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells Blood 2009 114 12 2411 2416
51. Tupin E., Nicoletti A., Elhage R., CD1d-dependent activation of NKT cells aggravates atherosclerosis The Journal of Experimental Medicine 2004 199 3 417 422
52. Mahley R. W., Rall S. C. Jr., Apolipoprotein E: far more than a lipid transport protein Annual Review of Genomics and Human Genetics 2000 1 2000 507 537
53. Fazekas F., Strasser-Fuchs S., Kollegger H., Apolipoprotein E 4 is associated with rapid progression of multiple sclerosis Neurology 2001 57 5 853 857
54. Brown C. M., Choi E., Xu Q., Vitek M. P., Colton C. A., The APOE4 genotype alters the response of microglia and macrophages to 17 -estradiol Neurobiology of Aging 2008 29 12 1783 1794
55. Maezawa I., Maeda N., Montine T. J., Montine K. S., Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice Journal of Neuroinflammation 2006 3 1 10
56. Jofre-Monseny L., Minihane A.-M., Rimbach G., Impact of apoE genotype on oxidative stress, inflammation and disease risk Molecular Nutrition Food Research 2008 52 1 131 145 (Pubitemid 351211806)
57. Misra U. K., Adlakha C. L., Gawdi G., McMillian M. K., Pizzo S. V., Laskowitz D. T., Apolipoprotein E and mimetic peptide initiate a calcium-dependent signaling response in macrophages Journal of Leukocyte Biology 2001 70 4 677 683
58. Ruiz J., Kouiavskaia D., Migliorini M., The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor Journal of Lipid Research 2005 46 8 1721 1731
59. Compston A., Coles A., Multiple sclerosis The Lancet 2008 372 9648 1502 1517
60. Schmechel D. E., Saunders A. M., Strittmatter W. J., Increased amyloid -peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 1993 90 20 9649 9653
61. De Stefano N., Bartolozzi M. L., Nacmias B., Influence of apolipoprotein E 4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis Archives of Neurology 2004 61 4 536 540
62. Utermann G., Steinmetz A., Weber W., Genetic control of human apolipoprotein E polymorphismml: comparison of one- and two-dimensional techniques of isoprotein analysis Human Genetics 1982 60 4 344 351
63. Menzel H. J., Kladetzky R. G., Assmann G., Apolipoprotein E polymorphism and coronary artery disease Arteriosclerosis 1983 3 4 310 315
64. Bielekova B., Martin R., Development of biomarkers in multiple sclerosis Brain 2004 127 7 1463 1478
65. Jin T., Hu L.-S., Chang M., Wu J., Winblad B., Zhu J., Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients European Journal of Neurology 2007 14 5 563 568
66. Yang Y.-R., Liu S.-L., Qin Z.-Y., Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barr syndrome Cellular and Molecular Neurobiology 2008 28 5 737 744
67. Gaillard O., Gervais A., Meillet D., Delattre J., Lyon-Cae O., Schuller E., Apolipoprotein E intrathecal synthesis is decreased in multiple sclerosis patients Annals of Clinical Biochemistry 1996 33 2 148 150
68. Gaillard O., Gervais A., Meillet D., Apolipoprotein E and multiple sclerosis: a biochemical and genetic investigation Journal of the Neurological Sciences 1998 158 2 180 186
69. Gelman B. B., Rifai N., Christenson R. H., Silverman L. M., Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis Annals of Clinical Laboratory Science 1988 18 1 46 52
70. Linton M. F., Gish R., Hubl S. T., Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation The Journal of Clinical Investigation 1991 88 1 270 281
71. Mahley R. W., Weisgraber K. H., Huang Y., Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS Journal of Lipid Research 2009 50 supplement S183 S188
72. Teunissen C. E., Dijkstra P. C., Polman C., Biological markers in CSF and blood for axonal degeneration in multiple sclerosis Lancet Neurology 2005 4 1 32 41
73. Chiasserini D., Di Filippo M., Candeliere A., CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis European Journal of Neurology 2008 15 9 998 1001
74. Haines J. L., Ter-Minassian M., Bazyk A., A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex Nature Genetics 1996 13 4 469 471
75. Becker K. G., Simon R. M., Bailey-Wilson J. E., Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases Proceedings of the National Academy of Sciences of the United States of America 1998 95 17 9979 9984
76. Xing C., Sestak A. L., Kelly J. A., Localization and replication of the systemic lupus erythematosus linkage signal at 4p16: interaction with 2p11, 12q24 and 19q13 in European Americans Human Genetics 2007 120 5 623 631
77. Gerdes L. U., The common polymorphism of apolipoprotein E: geographical aspects and new pathophysiological relations Clinical Chemistry and Laboratory Medicine 2003 41 5 628 631
78. Bulman D. E., Ebers G. C., The geography of MS reflects genetic susceptibility Journal of Tropical and Geographical Neurology 1992 2 1 66 72
79. Ferri C., Sciacca F. L., Veglia F., APOE 24 and -491 polymorphisms are not associated with MS Neurology 1999 53 4 888 889
80. Masterman T., Zhang Z., Hellgren D., APOE genotypes and disease severity in multiple sclerosis Multiple Sclerosis 2002 8 2 98 103
81. Gerdes L. U., Klausen I. C., Sihm I., Frgeman O., Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world Genetic Epidemiology 1992 9 3 155 167
82. Al-Shammri S., Fatania H., Al-Radwan R., Akanji A. O., The relationship of APOE genetic polymorphism with susceptibility to multiple sclerosis and its clinical phenotypes in Kuwaiti Arab subjects Clinica Chimica Acta 2005 351 1-2 203 207
83. Pinholt M., Frederiksen J. L., Andersen P. S., Christiansen M., Apo E in multiple sclerosis and optic neuritis: the Apo E- 4 allele is associated with progression of multiple sclerosis Multiple Sclerosis 2005 11 5 511 515
84. Hgh P., Oturai A., Schreiber K., Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate Multiple Sclerosis 2000 6 4 226 230
85. Hafler D. A., Compston A., Sawcer S., Risk alleles for multiple sclerosis identified by a genomewide study The New England Journal of Medicine 2007 357 9 851 862
86. Burwick R. M., Ramsay P. P., Haines J. L., APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers Neurology 2006 66 9 1373 1383
87. Bonetti A., Koivisto K., Pirttil T., A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility Journal of Neuroimmunology 2009 208 1-2 119 124
88. Schmidt S., Barcellos L. F., DeSombre K., Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis American Journal of Human Genetics 2002 70 3 708 717
89. Mustafina O. E., Bakhtiiarova K. Z., Mikhlova A. M., Analysis of the association of allelic variants of apolypoprotein E and interleukin 1 beta genes with multiple sclerosis in ethnic Tatars Genetika 2008 44 3 407 413
90. Huang R., Hughes M., Mobley S., Lanham I., Poduslo S. E., APOE genotypes in African American female multiple sclerosis patients Neuroscience Letters 2007 414 1 51 56
91. Chapman J., Vinokurov S., Achiron A., APOE genotype is a major predictor of long-term progression of disability in MS Neurology 2001 56 3 312 316
92. Ballerini C., Campani D., Rombol G., Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis Neuroscience Letters 2000 296 2-3 174 176
93. Enzinger C., Ropele S., Strasser-Fuchs S., Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E 4 allele Archives of Neurology 2003 60 1 65 70
94. Evangelou N., Jackson M., Beeson D., Palace J., Association of the APOE 4 allele with disease activity in multiple sclerosis Journal of Neurology Neurosurgery and Psychiatry 1999 67 2 203 205
95. Santos M., do Carmo Costa M., Edite Rio M., Genotypes at the APOE and SCA2 loci do not predict the course of multiple sclerosis in patients of Portuguese origin Multiple Sclerosis 2004 10 2 153 157
96. Kantarci O. H., Hebrink D. D., Achenbach S. J., Association of APOE polymorphisms with disease severity in MS is limited to women Neurology 2004 62 5 811 814
97. Sedano Ma. J., Calmarza P., Perez L., Trejo J. M., No association of apolipoprotein E 4 genotype with faster progression or less recovery of relapses in a Spanish cohort of multiple sclerosis Multiple Sclerosis 2006 12 1 13 18
98. Niino M., Kikuchi S., Fukazawa T., Yabe I., Tashiro K., Polymorphisms of apolipoprotein E and Japanese patients with multiple sclerosis Multiple Sclerosis 2003 9 4 382 386 (Pubitemid 36958021)
99. Koutsis G., Panas M., Karadima G., APOE genotypes in Greek multiple sclerosis patients: No effect on the MS Severity Score Journal of Neurology 2007 254 3 394 395
100. van der Walt A., Stankovich J., Bahlo M., Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy Neurology 2009 73 13 1018 1025
101. Zwemmer J. N.P., van Veen T., van Winsen L., No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis Multiple Sclerosis 2004 10 3 272 277
102. Pinholt M., Frederiksen J. L., Christiansen M., The association between apolipoprotein E and multiple sclerosis European Journal of Neurology 2006 13 6 573 580
103. Schreiber K., Oturai A. B., Ryder L. P., Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRBI 1501, CCR5 deletion mutation, apolipoprotein E) Multiple Sclerosis 2002 8 4 295 298
104. Enzinger C., Ropele S., Smith S., Accelerated evolution of brain atrophy and black holes in MS patients with APOE- 4 Annals of Neurology 2004 55 4 563 569
105. Fazekas F., Strasser-Fuchs S., Schmidt H., Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis Journal of Neurology Neurosurgery and Psychiatry 2000 69 1 25 28
106. Cocco E., Sotgiu A., Costa G., HLA-DR,DQ and APOE genotypes and gender influence in Sardinian primary progressive MS Neurology 2005 64 3 564 566
107. Savettieri G., Andreoli V., Bonavita S., Apolipoprotein E genotype does not influence the progression of multiple sclerosis Journal of Neurology 2003 250 9 1094 1098
108. Pinholt M., Frederiksen J. L., Andersen P. S., Christiansen M., Apo E in multiple sclerosis and optic neuritis: the Apo E- 4 allele is associated with progression of multiple sclerosis Multiple Sclerosis 2005 11 5 511 515
109. Ramagopalan S. V., DeLuca G. C., Morrison K. M., No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis Journal of Neuroimmunology 2007 186 1-2 156 160
110. Rao S. M., Leo G. J., Ellington L., Nauertz T., Bernardin L., Unverzagt F., Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning Neurology 1991 41 5 692 696
111. Rao S. M., Leo G. J., Bernardin L., Unverzagt F., Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction Neurology 1991 41 5 685 691
112. Shi J., Zhao C. B., Vollmer T. L., Tyry T. M., Kuniyoshi S. M., APOE 4 allele is associated with cognitive impairment in patients with multiple sclerosis Neurology 2008 70 3 185 190
113. Savettieri G., Messina D., Andreoli V., Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis Journal of Neurology 2004 251 10 1208 1214
114. Koutsis G., Panas M., Giogkaraki E., APOE 4 is associated with impaired verbal learning in patients with MS Neurology 2007 68 8 546 549
115. Sadovnick A. D., Jacobs D. H., MS and cognition and APOE: the ongoing conundrum about biomarkers Neurology 2008 70 3 164 165
116. Bakshi R., Czarnecki D., Shaikh Z. A., Brain MRI lesions and atrophy are related to depression in multiple sclerosis NeuroReport 2000 11 6 1153 1158
117. Berg D., Supprian T., Thomae J., Lesion pattern in patients with multiple sclerosis and depression Multiple Sclerosis 2000 6 3 156 162
118. Julian L. J., Vella L., Frankel D., Minden S. L., Oksenberg J. R., Mohr D. C., ApoE alleles, depression and positive affect in multiple sclerosis Multiple Sclerosis 2009 15 3 311 315
119. Furlan R., Cuomo C., Martino G., Animal models of multiple sclerosis Methods in Molecular Biology 2009 549 157 173
120. Shore V. G., Smith M. E., Perret V., Laskaris M. A., Alterations in plasma lipoproteins and apolipoproteins in experimental allergic encephalomyelitis Journal of Lipid Research 1987 28 2 119 129
121. Karussis D., Michaelson D. M., Grigoriadis N., Lack of apolipoprotein-E exacerbates experimental allergic encephalomyelitis Multiple Sclerosis 2003 9 5 476 480
122. Han X., Cheng H., Fryer J. D., Fagan A. M., Holtzman D. M., Novel role for apolipoprotein E in the central nervous systemml: modulation of sulfatide content The Journal of Biological Chemistry 2003 278 10 8043 8051
123. Schmann J., De Libero G., Serum lipoproteins: trojan horses of the immune response? Trends in Immunology 2006 27 2 57 59
124. Li F.-Q., Sempowski G. D., McKenna S. E., Laskowitz D. T., Colton C. A., Vitek M. P., Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis The Journal of Pharmacology and Experimental Therapeutics 2006 318 3 956 965
125. Laskowitz D. T., Thekdi A. D., Thekdi S. D., Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides Experimental Neurology 2001 167 1 74 85
126. Tu J.-l., Zhao C.-B., Vollmer T., APOE 4 polymorphism results in early cognitive deficits in an EAE model Biochemical and Biophysical Research Communications 2009 384 4 466 470
127. Shi J., Zhao C. B., Vollmer T. L., Tyry T. M., Kuniyoshi S. M., APOE 4 allele is associated with cognitive impairment in patients with multiple sclerosis Neurology 2008 70 3 185 190
128. Sriram S., Steiner I., Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis Annals of Neurology 2005 58 6 939 945
129. Weisgraber K. H., Mahley R. W., Human apolipoprotein E: the Alzheimer's disease connection The FASEB Journal 1996 10 13 1485 1494
130. Gregg R. E., Zech L. A., Schaefer E. J., Abnormal in vivo metabolism of apolipoprotein E4 in humans The Journal of Clinical Investigation 1986 78 3 815 821
131. Weisgraber K. H., Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112 Journal of Lipid Research 1990 31 8 1503 1511
132. Innerarity T. L., Pitas R. E., Mahley R. W., Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts The Journal of Biological Chemistry 1979 254 10 4186 4190
133. Narita M., Holtzman D. M., Fagan A. M., Cellular catabolism of lipid poor apolipoprotein E via cell surface LDL receptor-related protein Journal of Biochemistry 2002 132 5 743 749
134. Wang B., Jin F., Yang Z., The insertion polymorphism in angiotensin-converting enzyme gene associated with the APOE 4 allele increases the risk of late-onset alzheimer disease Journal of Molecular Neuroscience 2006 30 3 267 271